DRI Healthcare Trust Closes Previously Announced Refinancing of Preferred Securities

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

DRI Healthcare Trust Closes Previously Announced Refinancing of Preferred Securities

Canada NewsWire

– Transaction significantly reduces potential dilution with a net reduction of warrants equivalent to 8.2% of units outstanding –

TORONTO, April 23, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") announces the closing of its previously announced preferred securities refinancing, whereby its US$114,760,000 aggregate principal amount of Series A and Series B preferred securities and 6,369,180 warrants were exchanged for US$135,202,000 aggregate principal amount of new Series C preferred securities and 1,749,996 new warrants. The new warrants have an exercise price of US$15.00, representing a 20% premium to the five day volume-weighted average price of the Trust's units.

"We will continue to seek to optimize our capital structure to lower our cost of capital," said Behzad Khosrowshahi, Chief Executive Officer of the Trust. "We have addressed potential dilution concerns by retiring approximately 6.4 million in-the-money warrants and replacing them with approximately 1.7 million out-of-the-money warrants. The transaction did not involve any cash out from the Trust and our fully diluted share count is reduced by 4.6 million, or 8.2% of units outstanding, following the transaction."

Scotia Capital Inc. acted as exclusive financial advisor to the Trust.

About DRI Healthcare Trust

DRI Healthcare Trust is managed by DRI Capital Inc. ("DRI Healthcare"), the pioneer in global pharmaceutical royalty monetization with a 35-year history of accelerating innovation by providing capital to inventors, academic institutions and biopharma companies. Since its founding in 1989, DRI Healthcare has deployed more than US$3.0 billion, acquiring more than 70 royalties on 45-plus drugs, including Eylea, Keytruda, Orserdu, Spinraza, Stelara, Vonjo, Zejula and Zytiga. DRI Healthcare Trust's units are listed and trade on the Toronto Stock Exchange in Canadian dollars under the symbol "DHT.UN" and in U.S. dollars under the symbol "DHT.U". To learn more, visit drihealthcare.com or follow us on LinkedIn.

SOURCE DRI Healthcare Trust

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/April2024/23/c2913.html

Copyright CNW Group 2024

Comment On!

Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).